drugset / Trial / NCT01928693
A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.
Phase 2
Terminated
2 enrolled
Cornea Consultants Of Nashville
Bausch & Lomb Incorporated · collabSCRI Development Innovations, LLC · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This Phase II study will evaluate the safety and efficacy of three fluoroquinolone ophthalmic agents to determine the optimal treatment in patients with infectious corneal ulcers.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-05
- Completion
- 2014-05
Outcome
Outcome not reported
Stopped (Enrollment): “study terminated due to slow accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Besifloxacin | Small molecule | 0.6 % | Topical |
| Comparator | Gatifloxacin | Small molecule | 0.5 % | Topical |
| Comparator | Moxifloxacin | Small molecule | 0.5 % | Topical |